Interleukin‐17 and interleukin‐22 promote tumor progression in human nonmelanoma skin cancer

E-ISSN： 1521-4141|45|3|922-931

ISSN： 0014-2980

Source： EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.45, Iss.3, 2015-03, pp. : 922-931

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin (IL)‐17A and IL‐22‐producing neutrophils in psoriatic skin

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : e321-e322

John Wiley & Sons Inc

Access to resources Recommend Favorite

A catch‐22: Interleukin‐22 and cancer

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 1, 2018-01 ,pp. : 15-31

John Wiley & Sons Inc

Access to resources Recommend Favorite

Th17 cytokines in non‐melanoma skin cancer

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 3, 2015-03 ,pp. : 692-694

John Wiley & Sons Inc

Access to resources Recommend Favorite

Obesity exacerbates imiquimod‐induced psoriasis‐like epidermal hyperplasia and interleukin‐17 and interleukin‐22 production in mice

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 6, 2015-06 ,pp. : 436-442

John Wiley & Sons Inc

Access to resources Recommend Favorite

Staphylococcal Exotoxins Induce Interleukin 22 in Human Th22 Cells

International Archives of Allergy and Immunology, Vol. 165, Iss. 1, 2014-10 ,pp. : 35-39

Karger

Access to resources Recommend Favorite